|
nContact Surgical, a cardiac solution company, will embark on a clinical trial to probe whether a convergent ablation procedure -- combining endoscopic with catherter ablation -- can effectively treat patients with symptomatic paroxysmal atrial fibrillation (AF).
|
The FDA has granted marketing approval to Biosense Webster's NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation (a-fib), when used with compatible 3D electroanatomic mapping systems.
|